Takeda invests in microdose tech collaborator Presage Biosciences
Takeda has invested in Presage Biosciences whose tech platform is designed to let pharmas test multiple cancer drug combinations in a single trial.
Archives for August 19, 2015
Italy bans 7 APIs from compounding pharmacies after off-label abuse
The Italian Ministry of Health has banned compounding pharmacies from preparing drugs containing any of seven APIs after chemists were discovered making dangerous off-label weight loss treatments.
Valeant to buy "female viagra" maker Sprout for $1bn
Valeant Pharmaceuticals is set to buy Addyi maker Sprout Pharmaceuticals under a $1bn (€895m) deal agreed today.
Major INC Research investor sells shares for $177m
INC Research investor Avista Capital Partners has offloaded shares just days after the CRO was upgraded by a number of analysts.
Unilife whistleblower case blows over; Ex-exec apologises
An erstwhile whistleblower who accused Unilife of fraud and violating US FDA validation regulations has apologised and withdrawn his allegations.
Merck recalls 276,000 pill bottles
Merck & Co. has recalled two chemotherapy products because of cracked caps, including one it manufactures for Novartis’ Sandoz.
Xellia moves US HQ to North Carolina
Anti-infectives firm Xellia has moved its North American HQ to the lyophilisation plant in Raleigh, North Carolina that it bought from Fresenius Kabi last July.